Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Big Ten Cancer Research Consortium
Big Ten Cancer Research Consortium
VA Office of Research and Development
Jonsson Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Nerviano Medical Sciences
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Jiangsu HengRui Medicine Co., Ltd.
Columbia University
National Institutes of Health Clinical Center (CC)
BeiGene
Impact Therapeutics, Inc.
Shanghai Huilun Pharmaceutical Co., Ltd.
Eastern Cooperative Oncology Group
University of Colorado, Denver
Massachusetts General Hospital
Guangzhou Medical University
Taizhou Hospital
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
China Medical University, China
Memorial Sloan Kettering Cancer Center
Chinese PLA General Hospital
Chinese PLA General Hospital
Far Eastern Memorial Hospital
Fox Chase Cancer Center
Case Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Fox Chase Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Swiss Cancer Institute
Tufts Medical Center
Tel-Aviv Sourasky Medical Center